U.S. Specialty Stores Stock News

Amylyx Pharmaceuticals (AMLX) stock in focus Amylyx Pharmaceuticals (AMLX) has drawn investor attention after a period where the shares show a small loss over the past month, yet a gain over the past 3 months and year to date. See our latest analysis for Amylyx Pharmaceuticals. The recent 6.2% 1 day and 8.8% 7 day share price returns contrast with a 1.4% 30 day share price decline. At the same time, the 33.6% year to date share price return and very large 1 year total shareholder return...

Why Parker-Hannifin (PH) is on investors’ radar today Parker-Hannifin (PH) is back in focus after a recent share price move, with the stock last closing at US$1,014.97. That puts fresh attention on how its fundamentals line up at this level. See our latest analysis for Parker-Hannifin. The recent move to US$1,014.97 comes after a strong run, with a 30 day share price return of 9.61% and a 90 day share price return of 17.79%, alongside a 1 year total shareholder return of 56.39% that points to...

QuidelOrtho recently announced a long-term supply agreement with Lifotronic Technology to broaden its immunoassay analyzer platforms and add over 70 assays, including more than 25 not currently offered on its VITROS system, across select markets outside the United States. This collaboration could materially reshape QuidelOrtho’s international diagnostics offering by helping it compete for full‑menu tenders and better serve both small and high‑throughput laboratories. Next, we’ll examine how...

Southern BancShares (N.C.) (SBNC) has just wrapped up FY 2025 with fourth quarter revenue of US$122.7 million and basic EPS of US$912.54, capping a 12 month stretch where trailing revenue came in at US$195.5 million and EPS was US$901.30. Over recent quarters, the bank has seen revenue move from US$74.6 million and EPS of US$507.05 in Q3 FY 2024 to US$70.5 million and EPS of US$450.53 in Q2 FY 2025, before landing at the latest Q4 figures. Trailing net profit margin over the year sits at...

If you are wondering whether Unity Software's share price still reflects its underlying worth, you are not alone. This article is set up to help you frame that question more clearly. Unity closed at US$19.58, with a 5.9% move over the last 7 days. The 30 day, year to date and 1 year returns of 52.5%, 55.8% and 25.2% declines highlight how sentiment has shifted over different timeframes. Recent news on Unity has focused on ongoing interest in its role as a key platform for real time 3D...

In February 2026, Praxis Precision Medicines reported that its net loss widened to US$88.91 million for the fourth quarter and US$303.27 million for 2025, while basic loss per share from continuing operations rose to US$3.50 for the quarter and US$13.48 for the year. At the same time, Praxis filed New Drug Applications for ulixacaltamide and relutrigine, signaling a move toward potential commercialization backed by late-stage data and a cash position of about US$1.50 billion that management...

Soleno Therapeutics (SLNO) just closed out FY 2025 with fourth quarter revenue of US$91.7 million and basic EPS of US$0.81, alongside net income of US$42.9 million. This capped a trailing 12 month line that shows revenue of US$190.4 million and basic EPS of US$0.40. The company reported revenue of US$66.0 million in Q3 and US$32.7 million in Q2, while EPS moved from US$0.49 in Q3 and a small loss in Q2. Together, these figures describe a story where higher sales and a cleaner income line are...

Morgan Stanley Capital Partners agreed to acquire Security 101, a U.S. security integration provider serving sectors such as healthcare, government, and finance. EquityZen, a private shares marketplace acquired by Morgan Stanley Wealth Management in January, is cutting transaction fees for investors and shareholders on its platform. These moves highlight Morgan Stanley's effort to expand its security integration footprint and adjust its financial technology offerings for clients. Morgan...

Amentum Holdings recently secured an Industry Mission Partner contract from the UK Ministry of Defence’s Team Hypersonics to provide missile design engineering and program management for hypersonic strike capabilities under the AUKUS framework, while also reporting a steady start to FY2026 with 3% normalized growth and around US$1.00 billion in nuclear energy awards in FQ1. These developments, alongside progress integrating its 2024 merger with Jacobs Solutions and a shift toward...

Ducommun (DCO) has wrapped up FY 2025 with fourth quarter revenue of US$215.8 million and basic EPS of US$0.50, alongside net income of US$7.4 million. The trailing twelve month figures show revenue of US$824.7 million and a net loss of US$33.9 million tied to basic EPS of US$2.27. Over recent quarters, revenue has moved from US$197.3 million in Q4 2024 to US$215.8 million in Q4 2025, with quarterly basic EPS ranging from a loss of US$4.30 in Q3 2025 to a profit of US$0.50 in Q4 2025. For...

If you are wondering whether Nabors Industries shares still offer value at around US$77.80, you are not alone. The answer depends on how you look at the numbers. The stock has recently shown sharp moves, with returns of 1.6% over the past week, 15.7% over the last month, 40.4% year to date and 95.5% over the past year. The 3 year and 5 year returns sit at 51.0% and 31.9% declines respectively. These swings have kept Nabors Industries on the radar of investors who track companies where...

In February 2026, Natural England and Defra selected Jacobs Solutions to coordinate and deliver national-scale fieldwork for the England Ecosystem Survey, supporting collection of soil, vegetation and landscape data through to an expected conclusion in the first half of 2027. This role deepens Jacobs’ involvement in large-scale environmental policy infrastructure, aligning its consulting and program management capabilities with the U.K.’s Natural Capital and Ecosystem Assessment...

Wondering whether ManpowerGroup’s current share price still reflects its underlying worth, or if the market has moved on too quickly from this long established HR services name? The stock recently closed at US$27.90 and has seen returns of 3.9% decline over 7 days, 7.3% decline over 30 days, a 7.2% decline year to date, and a 47.8% decline over 1 year, with longer term returns of 62.5% decline over 3 years and 64.8% decline over 5 years. These moves come as investors continue to reassess...

Shake Shack (SHAK) has wrapped up FY 2025 with fourth quarter revenue of US$400.5 million and basic EPS of US$0.29, alongside trailing 12 month revenue of US$1.4 billion and EPS of US$1.14 that sit against very large reported earnings growth of 341.7% over the past year. The company has seen trailing 12 month revenue move from US$1.25 billion at the end of Q4 2024 to US$1.45 billion by Q4 2025, while trailing EPS stepped up from US$0.26 to US$1.14 and net profit margin shifted from 0.8% to...

Amazon.com (NasdaqGS:AMZN) is planning about $200b in capital spending to expand its AI and cloud infrastructure, including custom chips and new data centers. David Luan, who led Amazon's artificial intelligence lab focused on AGI, has resigned following an internal AI division reorganization. AWS senior vice president Peter Desantis is taking over leadership of advanced AI efforts, tying them more closely to Amazon Web Services. Amazon.com, trading around $207.92, is in the middle of a...

If you are wondering whether Elastic's current share price reflects its true worth, you are not alone. This article focuses squarely on what the numbers say about value. The stock last closed at US$61.58, after a 7 day return of a 0.8% decline, a 30 day return of a 17.0% decline, a year to date return of a 15.1% decline, and a 1 year return of a 39.2% decline, compared with a 3 year return of 5.4% and a 5 year return of a 49.9% decline. Recent coverage has focused on Elastic's position in...

Earlier this month, CMS Energy announced that retired Dominion Energy COO Diane Leopold and Meijer CEO Richard Keyes joined the CMS Energy and Consumers Energy boards, with Leopold assigned to the Compensation and Human Resources and Finance Committees and Keyes to the Audit and Governance, Sustainability and Public Responsibility Committees. The addition of a seasoned utility operator and a retail chief executive strengthens board oversight across capital allocation, executive pay, risk,...

In February 2026, Marcus & Millichap, Inc. reported fourth-quarter 2025 revenue of US$243.95 million and net income of US$13.31 million, alongside full-year 2025 revenue of US$755.16 million and a net loss of US$1.91 million, while also disclosing that it completed a share repurchase program totaling 3,146,936 shares for US$98.00 million. These results show improved quarterly profitability and a smaller full-year loss compared with the prior year, while the completed buyback reduced the...

Are you wondering if Global Industrial still offers good value after its recent run, or if the current price already reflects the key positives for the business? The stock last closed at US$33.26, with returns of 4.3% over 7 days, 9.9% over 30 days, 13.1% year to date, 48.4% over 1 year, 32.6% over 3 years and 10.4% over 5 years. This naturally raises questions about what is now priced in. Recent coverage has focused on Global Industrial's role as a distributor of industrial and business...

Relay Therapeutics (RLAY) has caught investor interest after a period of strong one year total return alongside significant multi year drawdowns. This has raised questions about how its current US$9.16 share price reflects those mixed outcomes. See our latest analysis for Relay Therapeutics. The recent 1 month share price return of 7.76% and 3 month share price return of 15.66%, alongside a 1 year total shareholder return of 181.85% but weak multi year total shareholder returns, suggest short...

Context for Manhattan Associates after recent share performance Manhattan Associates (MANH) has attracted fresh attention after a recent share pullback, with the stock down about 18% over the past month and 21% over the past 3 months. See our latest analysis for Manhattan Associates. That recent pullback sits within a tougher stretch for the stock, with a 7 day share price return of 2.74% decline and a year to date share price return of 16.54% decline, while the 1 year total shareholder...

Ingersoll Rand (IR) shares moved after quarterly results beat expectations, with adjusted earnings and revenue ahead of forecasts. At the same time, sizable insider selling by senior executives stirred questions about management sentiment and added to recent trading volatility. See our latest analysis for Ingersoll Rand. The latest move takes Ingersoll Rand’s share price to US$94.53, with a 1 day share price return of 1.62% and a 30 day share price return of 9.57%, while the 5 year total...

Structure Therapeutics Inc. recently filed a US$235.64 million shelf registration for 3,541,890 American Depositary Shares tied to its employee stock ownership plan, following earlier Phase 2 data showing significant weight loss with its oral GLP-1 candidate aleniglipron. These capital markets moves come on the heels of a large hedge fund increasing its position and a very large public offering, underscoring institutional interest in the company’s obesity-focused pipeline. Against this...

Axsome Therapeutics (NasdaqGM: AXSM) has started the CLARITY Phase 3 trial of solriamfetol in major depressive disorder with excessive daytime sleepiness. The trial focuses on a group of MDD patients who experience excessive daytime sleepiness, for which no approved treatments are currently available. This study expands Axsome's clinical program into an area of unmet medical need. Axsome Therapeutics, listed on the NasdaqGM under the ticker AXSM, develops therapies for central nervous...